STOCK TITAN

Frank Bennett sells $1.17M in IONS stock (IONS) — amended Form 144/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144/A

Rhea-AI Filing Summary

IONS amended a Form 144 filing reporting secondary sales of common stock by Frank Bennett. The amendment lists sales of $684,264 for 8,977 shares on 01/16/2026 and $487,898 for 5,885 shares on 01/30/2026.

The filing also lists securities available to be sold including 65,089 shares tied to an option exercise (grant date 01/03/2022) and 20,000 restricted stock units (grant date 01/15/2017), as shown in the "Securities To Be Sold" section.

Positive

  • None.

Negative

  • None.

Insights

Amendment shows reported insider sales and remaining equity instruments.

The amendment documents completed dispositions by Frank Bennett totaling $1,172,162 across 01/16/2026 and 01/30/2026, and lists option- and RSU-derived shares that may be sold.

These are secondary transactions by an insider; timing and further sales depend on holder decisions and any transfer restrictions noted in company equity plans.

144/A: Filer Information

144/A: Issuer Information

144/A: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

144/A: Remarks and Signature

FAQ

What did IONS' amended Form 144/A report about Frank Bennett's transactions?

The amendment reports two completed sales by Frank Bennett: 8,977 shares sold for $684,264 on 01/16/2026 and 5,885 shares sold for $487,898 on 01/30/2026. The filing lists these transactions as secondary sales.

Does the filing show other securities that may be sold for IONS?

Yes. The filing's "Securities To Be Sold" section lists 65,089 shares from an option exercise (grant date 01/03/2022) and 20,000 restricted stock units (grant date 01/15/2017), indicating additional equity instruments identified in the amendment.

Did IONS receive proceeds from the reported sales in the Form 144/A?

The amendment shows sales by an insider (Frank Bennett) with aggregate proceeds reported for each transaction, indicating these were secondary sales; the filing does not state that the issuer received proceeds from these transactions.

What are the dates of the transactions reported in the amendment for IONS?

The reported sale dates in the amendment are 01/16/2026 for 8,977 shares and 01/30/2026 for 5,885 shares. Grant dates for listed equity instruments are 01/03/2022 and 01/15/2017.

How much total cash did Frank Bennett's reported sales generate in the amendment?

The two sales reported generated a combined $1,172,162 in proceeds: $684,264 and $487,898, as shown next to each transaction in the amendment.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

13.28B
160.38M
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD